[시장보고서]세계의 무혈청 배지 시장 : 산업 분석, 규모, 점유율, 성장, 동향 예측(2024-2033년)

세계의 무혈청 배지 시장 : 산업 분석, 규모, 점유율, 성장, 동향 예측(2024-2033년)

Serum Free Media Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

상품코드 : 1547126

리서치사 : Persistence Market Research

발행일 : 2024년 08월

페이지 정보 : 영문 250 Pages

라이선스 & 가격 (부가세 별도)

US $ 4,995

￦ 7,216,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295

￦ 10,539,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495

￦ 12,273,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

Persistence Market Research는 전 세계 무혈청 배지 시장에 대한 종합적인 보고서를 발표했습니다. 이 보고서는 시장 성장 촉진요인, 동향, 기회, 과제 등 중요한 시장 역학을 상세하게 분석하고 시장 구조에 대한 자세한 통찰력을 제공합니다.

주요 인사이트

무혈청 배지 시장 규모(2024E) : 20억 달러
예측 시장 규모(2033F) : 38억 달러
세계 시장 성장률(CAGR 2024년부터 2033년까지) : 7.7%

무혈청 배지 시장 - 보고 범위:

무혈청 배지는 동물 유래 성분에 의한 오염의 위험을 배제하기 때문에 특히 치료·진단 목적의 세포 배양 응용에 필수적입니다. 이 시장은 바이오테크놀러지, 제약, 학술 연구 등 폭넓은 업계에 서비스를 제공하고, 특정 세포주나 용도에 맞춘 다양한 유형의 무혈청 배지를 제공합니다. 시장 성장은 생물학적 제제에 대한 수요 증가, 세포 배양 기술의 진보, 백신 생산 및 기타 치료 개발에서 무혈청 배지 채택 증가에 의해 촉진되고 있습니다.

시장 성장 촉진요인:

세계 무혈청 배지 시장은 안전성과 규제 준수를 향상시키기 위해 세포 배양에서 동물 유래 성분의 사용을 줄이는 것이 중요해지는 등 몇 가지 중요한 요인에 의해 견인되고 있습니다. 단클론항체 및 백신과 같은 바이오 의약품에 대한 수요 증가는 보다 일관되고 명확한 배양 환경을 보장하기 위해 무혈청 배지의 채용을 뒷받침하고 있습니다. 또한, 세포 배양 기술의 진보와 특정 세포주에 맞는 무혈청 제제 시장 개척이 시장 성장에 기여하고 있습니다. 맞춤형 의료의 추진과 재생 의료에서의 세포 기반 연구의 확대도 무혈청 배지 수요 촉진에 중요한 역할을 하고 있습니다.

시장 성장 억제요인:

유망한 성장 전망에도 불구하고, 무혈청 배지 시장은 높은 시장 개척 비용과 기술적 복잡성과 관련된 문제에 직면하고 있습니다. 무혈청 배지의 제형화는 다양한 세포주와의 적합성을 보장하기 위한 광범위한 R&D 노력을 필요로 하며, 이는 생산 비용을 증가시킬 수 있습니다. 또한, 혈청 함유 배지에서 무혈청 배지로의 전이는 광범위한 검증 및 최적화 프로세스가 필요하기 때문에 연구자에게 어려울 수 있습니다. 종래의 배지와 비교하여 무혈청 배지의 비용이 높은 것도, 특히 소규모의 연구소나 연구 기관에 있어서는 제한 요인이 될 수 있습니다.

시장 기회:

무혈청 배지 시장은 바이오 의약품 연구개발에 대한 투자 증가, 생물제제 및 바이오시밀러의 상승, 세포치료 및 유전자치료에 대한 주목 증가에 의해 큰 성장 기회를 가져오고 있습니다. 줄기 세포 배양 및 3D 세포 배양과 같은 특정 용도에 대응하는 새로운 무혈청 배지 제제의 개척은 시장 확대의 새로운 길을 제공합니다. 게다가 지속가능하고 윤리적인 연구 관행이 중시되고, 무혈청 배지의 채용이 더욱 촉진될 것으로 예상됩니다. 연구 기관 및 바이오 제약 기업과의 전략적 파트너십은 기술 혁신과 비용 효율적인 솔루션에 대한 투자와 함께 이러한 새로운 기회를 활용하는 데 매우 중요합니다.

이 보고서에서 다루는 주요 질문

무혈청 배지 시장의 세계 성장을 가속하는 주요 요인은?
무혈청 배지의 유형과 제형은 어떤 산업에서 채택되고 있는가?
기술의 진보는 무혈청 배지 시장 경쟁 구도에 어떤 영향을 미치는가?
무혈청 배지 시장에 기여하는 주요 기업은 누구이며 시장 관련성을 유지하기 위해 어떤 전략을 채택하고 있는가?
세계의 무혈청 배지 시장에서의 새로운 동향과 장래성은?

소개/주요 조사 결과
시장 규모(10억 달러) 분석, 2019-2023년
시장 규모(10억 달러) 분석과 예측, 2024-2033년
- 단백질 발현 배지
- 줄기세포 배지
- 하이브리도마 배지
- 1차 세포 배지
- 곤충 세포 배지
- 면역학 배지
- CHO 세포 배지
- 화학적 정의 배지
배지별 시장의 매력 분석

제9장 최종 사용자별: 세계 시장 분석

소개/주요 조사 결과
시장 규모(10억 달러) 분석, 2019-2023년
시장 규모(10억 달러) 분석과 예측, 2024-2033년
- 바이오의약품기업
- 임상연구기관
- 학술연구센터
최종 사용자별 시장의 매력 분석

제10장 지역별: 세계 시장 분석

소개/주요 조사 결과
시장 규모(10억 달러) 분석, 2019-2023년
시장 규모(10억 달러) 분석과 예측, 2024-2033년
- 북미
- 라틴아메리카
- 유럽
- 동아시아
- 남아시아
- 오세아니아
- 중동 및 아프리카
지역별 시장의 매력 분석

제11장 북미 시장 분석

제12장 라틴아메리카 시장 분석

제13장 유럽 시장 분석

제14장 동아시아 시장 분석

제15장 남아시아 시장 분석

제16장 오세아니아 시장

제17장 중동 및 아프리카 시장 분석

제18장 시장 구조 분석

기업 Tier별 시장 분석
주요 기업의 시장 점유율 분석
시장현재분석

제19장 경쟁 분석

경쟁 대시보드
경쟁 벤치마킹
경쟁의 상세
- Thermo Fisher Scientific Inc.
- Merck KGaA
- GE Healthcare
- Lonza
- Corning Incorporated
- Irvine Scientific
- STEMCELL Technologies
- PAN Biotech
- MP Biomedicals, LLC
- PromoCell GmbH
- Sartorius AG

제20장 사용된 전제조건과 약어

제21장 조사 방법

JHS

영문 목차

영문목차

Persistence Market Research has recently released a comprehensive report on the global Serum Free Media Market. The report provides an in-depth analysis of critical market dynamics, including drivers, trends, opportunities, and challenges, offering detailed insights into the market structure.

Key Insights:

Serum Free Media Market Size (2024E): USD 2.0 Bn
Projected Market Value (2033F): USD 3.8 Bn
Global Market Growth Rate (CAGR 2024 to 2033): 7.7%

Serum Free Media Market - Report Scope:

Serum free media are essential in cell culture applications, particularly for therapeutic and diagnostic purposes, as they eliminate the risk of contamination associated with animal-derived components. The market serves a wide range of industries, including biotechnology, pharmaceuticals, and academic research, providing various types of serum free media tailored for specific cell lines and applications. The market's growth is fueled by the increasing demand for biologics, advancements in cell culture technologies, and the rising adoption of serum free media in vaccine production and other therapeutic developments.

Market Growth Drivers:

The global serum free media market is driven by several key factors, including the growing emphasis on reducing the use of animal-derived components in cell culture to improve safety and regulatory compliance. The increasing demand for biopharmaceuticals, such as monoclonal antibodies and vaccines, is boosting the adoption of serum free media, as it ensures a more consistent and defined culture environment. Additionally, advancements in cell culture technologies and the development of tailored serum free formulations for specific cell lines are contributing to market growth. The push towards personalized medicine and the expansion of cell-based research in regenerative medicine also play significant roles in driving demand for serum free media.

Market Restraints:

Despite promising growth prospects, the serum free media market faces challenges related to high development costs and technical complexities. The formulation of serum free media requires extensive R&D efforts to ensure compatibility with different cell lines, which can increase production costs. Additionally, the transition from serum-containing to serum free media can be challenging for researchers due to the need for extensive validation and optimization processes. The high cost of serum free media compared to traditional media can also be a limiting factor, particularly for small-scale laboratories and research institutions.

Market Opportunities:

The serum free media market presents significant growth opportunities driven by increasing investments in biopharmaceutical R&D, the rise of biologics and biosimilars, and the growing focus on cell and gene therapy. The development of novel serum free media formulations that cater to specific applications, such as stem cell culture and 3D cell culture, offers new avenues for market expansion. Additionally, the growing emphasis on sustainable and ethical research practices is expected to further drive the adoption of serum free media. Strategic partnerships with research institutions and biopharmaceutical companies, along with investment in innovation and cost-effective solutions, are crucial to capitalizing on these emerging opportunities.

Key Questions Answered in the Report:

What are the primary factors driving the growth of the serum free media market globally?
Which serum free media types and formulations are leading adoption across different industries?
How are technological advancements influencing the competitive landscape of the serum free media market?
Who are the key players contributing to the serum free media market, and what strategies are they employing to maintain market relevance?
What are the emerging trends and future prospects in the global serum free media market?

Competitive Intelligence and Business Strategy:

Leading players in the global serum free media market, including Thermo Fisher Scientific, Merck KGaA, and Lonza Group, focus on innovation, product differentiation, and strategic collaborations to maintain a competitive edge. These companies invest in R&D to develop advanced serum free media solutions tailored for various cell lines and applications, ensuring compliance with stringent regulatory standards. Partnerships with biopharmaceutical companies, academic institutions, and research organizations facilitate market access and promote the adoption of serum free media. The emphasis on sustainability, ethical research practices, and performance enhancement drives market growth and reinforces the position of key players in the evolving life sciences sector.

Key Companies Profiled:

Thermo Fisher Scientific Inc.
Merck KGaA
GE Healthcare
Lonza
Corning Incorporated
Irvine Scientific
STEMCELL Technologies
PAN Biotech
MP Biomedicals, LLC
PromoCell GmbH
Sartorius AG

Key Segments Covered in Serum free media Industry Research

Media:

Protein Expression Media
Stem Cell Media
Hybridoma Media
Primary Cell Media
Insect Cell Media
Immunology Media
Chinese Hamster Ovary (CHO) Cell Culture Media

End User:

Biopharmaceutical Companies
Clinical Research Organizations
Academic Research Centers

Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa (MEA)

1. Executive Summary

1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market
3.2. Market Innovation / Development Trends

4. Key Success Factors

4.1. Key Regulations
4.2. Key Strategies Adoption by Manufacturers
4.3. Product Adoption Analysis
4.4. Key Development Analysis
4.5. Supply Chain Analysis
4.6. Pipeline Assessment
4.7. PESTEL Analysis
4.8. Porter's Analysis

5. Market Background

5.1. Macro-Economic Factors
- 5.1.1. Global GDP outlook
- 5.1.2. Global Healthcare Outlook
- 5.1.3. Global Cell Culture Media Market Outlook
5.2. Forecast Factors - Relevance & Impact
- 5.2.1. Growing Healthcare Expenditure
- 5.2.2. Demand for Serum-Free Media
- 5.2.3. Increase in Research and Development Funding and Grants
- 5.2.4. Increase in Academic Research
- 5.2.5. Industry Consolidation Activities
- 5.2.6. Historic and Current Revenue of key Players
- 5.2.7. Increasing Number of Clinical Research Activities
- 5.2.8. Increasing Number of Biopharmaceutical Research Activities
- 5.2.9. Cost of Manufacturing Serum Free Media
5.3. Market Dynamics
- 5.3.1. Drivers
- 5.3.2. Restraints
- 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

6.1. COVID-19 and Impact Analysis
- 6.1.1. By Media
- 6.1.2. By End User
- 6.1.3. By Country
6.2. 2024 Market Scenario

7. Global Market Demand (in Value or Size in US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033

7.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
7.2. Current and Future Market Size (US$ Bn) Analysis and Forecast by Market Taxonomy, 2024-2033
- 7.2.1. Y-o-Y Growth Trend Analysis
- 7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Media

8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Bn) Analysis by Media, 2019-2023
8.3. Current and Future Market Size (US$ Bn) Analysis and Forecast by Media, 2024-2033
- 8.3.1. Protein Expression Media
- 8.3.2. Stem Cell Media
- 8.3.3. Hybridoma Media
- 8.3.4. Primary Cell Media
- 8.3.5. Insect Cell Media
- 8.3.6. Immunology Media
- 8.3.7. CHO Cell Media
- 8.3.8. Chemically Defined Media
8.4. Market Attractiveness Analysis by Media

9. Global Market Analysis 2019-2023 and Forecast 2024-2033, By End User

9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Bn) Analysis by End User, 2019-2023
9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast by End User, 2024-2033
- 9.3.1. Biopharmaceutical Companies
- 9.3.2. Clinical Research Organizations
- 9.3.3. Academic Research Centers
9.4. Market Attractiveness Analysis by End User

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Region

10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Bn) Analysis, by Region, 2019-2023
10.3. Current and Future Market Size (US$ Bn) Analysis Forecast by Region, 2024-2033
- 10.3.1. North America
- 10.3.2. Latin America
- 10.3.3. Europe
- 10.3.4. East Asia
- 10.3.5. South Asia
- 10.3.6. Oceania
- 10.3.7. Middle East & Africa
10.4. Market Attractiveness Analysis by Region

11. North America Market Analysis 2019-2023 and Forecast 2024-2033

11.1. Introduction
11.2. Historical Market Size (US$ Bn) Analysis Trend Analysis by Market Taxonomy, 2019-2023
11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast by Market Taxonomy, 2024-2033
- 11.3.1. By Country
  - 11.3.1.1. U.S.
  - 11.3.1.2. Canada
- 11.3.2. By Media
- 11.3.3. By End User
11.4. Market Attractiveness Analysis
- 11.4.1. By Country
- 11.4.2. By Media
- 11.4.3. By End User
11.5. Market Trends
11.6. Key Market Participants - Intensity Mapping
11.7. Drivers and Restraints - Impact Analysis
11.8. Country Level Analysis & Forecast
- 11.8.1. U.S. Market
  - 11.8.1.1. Introduction
  - 11.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 11.8.1.2.1. By Media
    - 11.8.1.2.2. By End User
- 11.8.2. Canada Market
  - 11.8.2.1. Introduction
  - 11.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 11.8.2.2.1. By Media
    - 11.8.2.2.2. By End User

12. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

12.1. Introduction
12.2. Historical Market Size (US$ Bn) Analysis Trend Analysis By Market Taxonomy, 2019-2023
12.3. Current and Future Market Size (US$ Bn) Analysis and Forecast by Market Taxonomy, 2024-2033
- 12.3.1. By Country
  - 12.3.1.1. Mexico
  - 12.3.1.2. Brazil
  - 12.3.1.3. Argentina
  - 12.3.1.4. Rest of Latin America
- 12.3.2. By Media
- 12.3.3. By End User
12.4. Market Attractiveness Analysis
- 12.4.1. By Country
- 12.4.2. By Media
- 12.4.3. By End User
12.5. Market Trends
12.6. Key Market Participants - Intensity Mapping
12.7. Drivers and Restraints - Impact Analysis
12.8. Country Level Analysis & Forecast
- 12.8.1. Mexico Market Analysis
  - 12.8.1.1. Introduction
  - 12.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 12.8.1.2.1. By Media
    - 12.8.1.2.2. By End User
- 12.8.2. Brazil Market Analysis
  - 12.8.2.1. Introduction
  - 12.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 12.8.2.2.1. By Media
    - 12.8.2.2.2. By End User
- 12.8.3. Argentina Market Analysis
  - 12.8.3.1. Introduction
  - 12.8.3.2. Market Analysis and Forecast by Market Taxonomy
    - 12.8.3.2.1. By Media
    - 12.8.3.2.2. By End User

13. Europe Market Analysis 2019-2023 and Forecast 2024-2033

13.1. Introduction
13.2. Historical Market Size (US$ Bn) Analysis Trend Analysis by Market Taxonomy, 2019-2023
13.3. Current and Future Market Size (US$ Bn) Analysis and Forecast by Market Taxonomy, 2024-2033
- 13.3.1. By Country
  - 13.3.1.1. Germany
  - 13.3.1.2. Italy
  - 13.3.1.3. France
  - 13.3.1.4. U.K.
  - 13.3.1.5. Spain
  - 13.3.1.6. BENELUX
  - 13.3.1.7. Russia
  - 13.3.1.8. Rest of Europe
- 13.3.2. By Media
- 13.3.3. By End User
13.4. Market Attractiveness Analysis
- 13.4.1. By Country
- 13.4.2. By Media
- 13.4.3. By End User
13.5. Market Trends
13.6. Key Market Participants - Intensity Mapping
13.7. Drivers and Restraints - Impact Analysis
13.8. Country Level Analysis & Forecast
- 13.8.1. Germany Market Analysis
  - 13.8.1.1. Introduction
  - 13.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 13.8.1.2.1. By Media
    - 13.8.1.2.2. By End User
- 13.8.2. Italy Market Analysis
  - 13.8.2.1. Introduction
  - 13.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 13.8.2.2.1. By Media
    - 13.8.2.2.2. By End User
- 13.8.3. France Market Analysis
  - 13.8.3.1. Introduction
  - 13.8.3.2. Market Analysis and Forecast by Market Taxonomy
    - 13.8.3.2.1. By Media
    - 13.8.3.2.2. By End User
- 13.8.4. U.K. Market Analysis
  - 13.8.4.1. Introduction
  - 13.8.4.2. Market Analysis and Forecast by Market Taxonomy
    - 13.8.4.2.1. By Media
    - 13.8.4.2.2. By End User
- 13.8.5. Spain Market Analysis
  - 13.8.5.1. Introduction
  - 13.8.5.2. Market Analysis and Forecast by Market Taxonomy
    - 13.8.5.2.1. By Media
    - 13.8.5.2.2. By End User
- 13.8.6. BENELUX Market Analysis
  - 13.8.6.1. Introduction
  - 13.8.6.2. Market Analysis and Forecast by Market Taxonomy
    - 13.8.6.2.1. By Media
    - 13.8.6.2.2. By End User
- 13.8.7. Russia Market Analysis
  - 13.8.7.1. Introduction
  - 13.8.7.2. Market Analysis and Forecast by Market Taxonomy
    - 13.8.7.2.1. By Media
    - 13.8.7.2.2. By End User

14. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

14.1. Introduction
14.2. Historical Market Size (US$ Bn) Analysis Trend Analysis By Market Taxonomy, 2019-2023
14.3. Current and Future Market Size (US$ Bn) Analysis and Forecast by Market Taxonomy, 2024-2033
- 14.3.1. By Country
  - 14.3.1.1. China
  - 14.3.1.2. Japan
  - 14.3.1.3. South Korea
- 14.3.2. By Media
- 14.3.3. By End User
14.4. Market Attractiveness Analysis
- 14.4.1. By Country
- 14.4.2. By Media
- 14.4.3. By End User
14.5. Market Trends
14.6. Key Market Participants - Intensity Mapping
14.7. Drivers and Restraints - Impact Analysis
14.8. Country Level Analysis & Forecast
- 14.8.1. China Market Analysis
  - 14.8.1.1. Introduction
  - 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 14.8.1.2.1. By Media
    - 14.8.1.2.2. By End User
- 14.8.2. Japan Market Analysis
  - 14.8.2.1. Introduction
  - 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 14.8.2.2.1. By Media
    - 14.8.2.2.2. By End User
- 14.8.3. South Korea Market Analysis
  - 14.8.3.1. Introduction
  - 14.8.3.2. Market Analysis and Forecast by Market Taxonomy
    - 14.8.3.2.1. By Media
    - 14.8.3.2.2. By End User

15. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

15.1. Introduction
15.2. Historical Market Size (US$ Bn) Analysis Trend Analysis By Market Taxonomy, 2019-2023
15.3. Current and Future Market Size (US$ Bn) Analysis and Forecast by Market Taxonomy, 2024-2033
- 15.3.1. By Country
  - 15.3.1.1. India
  - 15.3.1.2. Indonesia
  - 15.3.1.3. Malaysia
  - 15.3.1.4. Thailand
  - 15.3.1.5. Rest of South Asia
- 15.3.2. By Media
- 15.3.3. By End User
15.4. Market Attractiveness Analysis
- 15.4.1. By Country
- 15.4.2. By Media
- 15.4.3. By End User
15.5. Market Trends
15.6. Key Market Participants - Intensity Mapping
15.7. Drivers and Restraints - Impact Analysis
15.8. Country Level Analysis & Forecast
- 15.8.1. India Market Analysis
  - 15.8.1.1. Introduction
  - 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 15.8.1.2.1. By Media
    - 15.8.1.2.2. By End User
- 15.8.2. Indonesia Market Analysis
  - 15.8.2.1. Introduction
  - 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 15.8.2.2.1. By Media
    - 15.8.2.2.2. By End User
- 15.8.3. Malaysia Market Analysis
  - 15.8.3.1. Introduction
  - 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
    - 15.8.3.2.1. By Media
    - 15.8.3.2.2. By End User
- 15.8.4. Thailand Market Analysis
  - 15.8.4.1. Introduction
  - 15.8.4.2. Market Analysis and Forecast by Market Taxonomy
    - 15.8.4.2.1. By Media
    - 15.8.4.2.2. By End User

16. Oceania Market 2019-2023 and Forecast 2024-2033

16.1. Introduction
16.2. Historical Market Size (US$ Bn) Analysis Trend Analysis By Market Taxonomy, 2019-2023
16.3. Current and Future Market Size (US$ Bn) Analysis and Forecast by Market Taxonomy, 2024-2033
- 16.3.1. By Country
  - 16.3.1.1. Australia
  - 16.3.1.2. New Zealand
- 16.3.2. By Media
- 16.3.3. By End User
16.4. Market Attractiveness Analysis
- 16.4.1. By Media
- 16.4.2. By End User
16.5. Market Trends
16.6. Key Market Participants - Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis
16.8. Country Level Analysis & Forecast
- 16.8.1. Australia Market Analysis
  - 16.8.1.1. Introduction
  - 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 16.8.1.2.1. By Media
    - 16.8.1.2.2. By End User
- 16.8.2. New Zealand Market Analysis
  - 16.8.2.1. Introduction
  - 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 16.8.2.2.1. By Media
    - 16.8.2.2.2. By End User

17. Middle East and Africa (MEA) Market Analysis 2019-2023 and Forecast 2024-2033

17.1. Introduction
17.2. Historical Market Size (US$ Bn) Analysis Trend Analysis by Market Taxonomy, 2019-2023
17.3. Current and Future Market Size (US$ Bn) Analysis and Forecast by Market Taxonomy, 2024-2033
- 17.3.1. By Country
  - 17.3.1.1. GCC Countries
  - 17.3.1.2. Turkiye
  - 17.3.1.3. North Africa
  - 17.3.1.4. South Africa
  - 17.3.1.5. Rest of Middle East and Africa
- 17.3.2. By Media
- 17.3.3. By End User
17.4. Market Attractiveness Analysis
- 17.4.1. By Country
- 17.4.2. By Media
- 17.4.3. By End User
17.5. Market Trends
17.6. Key Market Participants - Intensity Mapping
17.7. Drivers and Restraints - Impact Analysis
17.8. Country Level Analysis & Forecast
- 17.8.1. GCC Countries Market Analysis
  - 17.8.1.1. Introduction
  - 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 17.8.1.2.1. By Media
    - 17.8.1.2.2. By End User
- 17.8.2. Turkiye Market Analysis
  - 17.8.2.1. Introduction
  - 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 17.8.2.2.1. By Media
    - 17.8.2.2.2. By End User
- 17.8.3. South Africa Market Analysis
  - 17.8.3.1. Introduction
  - 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
    - 17.8.3.2.1. By Media
    - 17.8.3.2.2. By End User
- 17.8.4. North Africa Market Analysis
  - 17.8.4.1. Introduction
  - 17.8.4.2. Market Analysis and Forecast by Market Taxonomy
    - 17.8.4.2.1. By Media
    - 17.8.4.2.2. By End User

18. Market Structure Analysis

18.1. Market Analysis by Tier of Companies
18.2. Market Share Analysis of Top Players
18.3. Market Presence Analysis

19. Competition Analysis

19.1. Competition Dashboard
19.2. Competition Benchmarking
19.3. Competition Deep Dive
- 19.3.1. Thermo Fisher Scientific Inc.
  - 19.3.1.1. Overview
  - 19.3.1.2. Media Portfolio
  - 19.3.1.3. Sales Footprint
  - 19.3.1.4. Key Financials
  - 19.3.1.5. SWOT Analysis
  - 19.3.1.6. Key Developments
  - 19.3.1.7. Strategy Overview
    - 19.3.1.7.1. Marketing Strategy
    - 19.3.1.7.2. Media Strategy
    - 19.3.1.7.3. Channel Strategy
- 19.3.2. Merck KGaA
  - 19.3.2.1. Overview
  - 19.3.2.2. Media Portfolio
  - 19.3.2.3. Sales Footprint
  - 19.3.2.4. Key Financials
  - 19.3.2.5. SWOT Analysis
  - 19.3.2.6. Key Developments
  - 19.3.2.7. Strategy Overview
    - 19.3.2.7.1. Marketing Strategy
    - 19.3.2.7.2. Media Strategy
    - 19.3.2.7.3. Channel Strategy
- 19.3.3. GE Healthcare
  - 19.3.3.1. Overview
  - 19.3.3.2. Media Portfolio
  - 19.3.3.3. Sales Footprint
  - 19.3.3.4. Key Financials
  - 19.3.3.5. SWOT Analysis
  - 19.3.3.6. Key Developments
  - 19.3.3.7. Strategy Overview
    - 19.3.3.7.1. Marketing Strategy
    - 19.3.3.7.2. Media Strategy
    - 19.3.3.7.3. Channel Strategy
- 19.3.4. Lonza
  - 19.3.4.1. Overview
  - 19.3.4.2. Media Portfolio
  - 19.3.4.3. Sales Footprint
  - 19.3.4.4. Key Financials
  - 19.3.4.5. SWOT Analysis
  - 19.3.4.6. Key Developments
  - 19.3.4.7. Strategy Overview
    - 19.3.4.7.1. Marketing Strategy
    - 19.3.4.7.2. Media Strategy
    - 19.3.4.7.3. Channel Strategy
- 19.3.5. Corning Incorporated
  - 19.3.5.1. Overview
  - 19.3.5.2. Media Portfolio
  - 19.3.5.3. Sales Footprint
  - 19.3.5.4. Key Financials
  - 19.3.5.5. SWOT Analysis
  - 19.3.5.6. Key Developments
  - 19.3.5.7. Strategy Overview
    - 19.3.5.7.1. Marketing Strategy
    - 19.3.5.7.2. Media Strategy
    - 19.3.5.7.3. Channel Strategy
- 19.3.6. Irvine Scientific
  - 19.3.6.1. Overview
  - 19.3.6.2. Media Portfolio
  - 19.3.6.3. Sales Footprint
  - 19.3.6.4. Key Financials
  - 19.3.6.5. SWOT Analysis
  - 19.3.6.6. Key Developments
  - 19.3.6.7. Strategy Overview
    - 19.3.6.7.1. Marketing Strategy
    - 19.3.6.7.2. Media Strategy
    - 19.3.6.7.3. Channel Strategy
- 19.3.7. STEMCELL Technologies
  - 19.3.7.1. Overview
  - 19.3.7.2. Media Portfolio
  - 19.3.7.3. Sales Footprint
  - 19.3.7.4. Key Financials
  - 19.3.7.5. SWOT Analysis
  - 19.3.7.6. Key Developments
  - 19.3.7.7. Strategy Overview
    - 19.3.7.7.1. Marketing Strategy
    - 19.3.7.7.2. Media Strategy
    - 19.3.7.7.3. Channel Strategy
- 19.3.8. PAN Biotech
  - 19.3.8.1. Overview
  - 19.3.8.2. Media Portfolio
  - 19.3.8.3. Sales Footprint
  - 19.3.8.4. Key Financials
  - 19.3.8.5. SWOT Analysis
  - 19.3.8.6. Key Developments
  - 19.3.8.7. Strategy Overview
    - 19.3.8.7.1. Marketing Strategy
    - 19.3.8.7.2. Media Strategy
    - 19.3.8.7.3. Channel Strategy
- 19.3.9. MP Biomedicals, LLC
  - 19.3.9.1. Overview
  - 19.3.9.2. Media Portfolio
  - 19.3.9.3. Sales Footprint
  - 19.3.9.4. Key Financials
  - 19.3.9.5. SWOT Analysis
  - 19.3.9.6. Key Developments
  - 19.3.9.7. Strategy Overview
    - 19.3.9.7.1. Marketing Strategy
    - 19.3.9.7.2. Media Strategy
    - 19.3.9.7.3. Channel Strategy
- 19.3.10. PromoCell GmbH
  - 19.3.10.1. Overview
  - 19.3.10.2. Media Portfolio
  - 19.3.10.3. Sales Footprint
  - 19.3.10.4. Key Financials
  - 19.3.10.5. SWOT Analysis
  - 19.3.10.6. Key Developments
  - 19.3.10.7. Strategy Overview
    - 19.3.10.7.1. Marketing Strategy
    - 19.3.10.7.2. Media Strategy
    - 19.3.10.7.3. Channel Strategy
- 19.3.11. Sartorius AG
  - 19.3.11.1. Overview
  - 19.3.11.2. Media Portfolio
  - 19.3.11.3. Sales Footprint
  - 19.3.11.4. Key Financials
  - 19.3.11.5. SWOT Analysis
  - 19.3.11.6. Key Developments
  - 19.3.11.7. Strategy Overview
    - 19.3.11.7.1. Marketing Strategy
    - 19.3.11.7.2. Media Strategy
    - 19.3.11.7.3. Channel Strategy